NCT06632730View on ClinicalTrials.gov

Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain

CompletedOBSERVATIONAL
Enrollment

69

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

November 20, 2023

Conditions
Spinal Muscular Atrophy Type ISpinal Muscular Atrophy Type II
Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT06632730 - Therapeutic Management and Use of Resources and Costs of Spinal Muscular Atrophy in Spain | Biotech Hunter | Biotech Hunter